News
Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...
11h
GlobalData on MSNTargeting energy expenditure: the next wave for obesity drugsBiotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...
Over a fifth of people in the UK have tried to access a weight loss drug in the last year, according to a recent poll.Authors Liz Breen Professor ...
This study of Medicare enrollees age 65 or older with type 2 diabetes found an association between semaglutide use and an increased ...
GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...
Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results